Quick Takeaways
- Mats Wahlstrom filed SCHEDULE 13D/A for TriSalus Life Sciences, Inc. Common Stock, $0.0001 par value (TLSI).
- Disclosed ownership: 6%.
- Date of event: 31 Jul 2025.
Mats Wahlstrom - 31 Jul 2025 SCHEDULE 13D/A Report for TriSalus Life Sciences, Inc. Common Stock, $0.0001 par value (TLSI)
- Filing Manager
- Mats Wahlstrom
- Reporting Manager
- Mats Wahlstrom
- Symbol
- TLSI
- Shares outstanding
- 49,798,017 shares
- Disclosed Ownership
- 2,987,881 shares
- Ownership
- 6%
- Form type
- SCHEDULE 13D/A
- Filing time
- 01 Aug 2025, 17:16:19 UTC
- Date of event
- 31 Jul 2025
- Previous filing
- 19 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Mats Wahlstrom disclosed 6% ownership in TriSalus Life Sciences, Inc. Common Stock, $0.0001 par value (TLSI) on 31 Jul 2025."
What Changed
- Previous schedule filing date: 19 Dec 2024.
- Current filing was accepted on 01 Aug 2025, 17:16.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Mats Wahlstrom | 6% | 2,987,881 | 1,617,853 | 1,370,028 | /s/ Mats Wahlstrom | Mats Wahlstrom | 0001459154 |
| Kerry R. Hicks | 4.7% | 2,349,795 | 979,767 | 1,370,028 | /s/ Kerry R. Hicks | Kerry R. Hicks | 0001110473 |
| HW Investment Partners, LLC | 2.8% | 1,370,028 | 0 | 1,370,028 | /s/ Mats Wahlstrom | Mats Wahlstrom | |
| HW Investment Partners, LLC | 2.8% | 1,370,028 | 0 | 1,370,028 | /s/ Kerry R. Hicks | Kerry R. Hicks |